Deborah Knobelman

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
South San Francisco, CA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Deborah Knobelman
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Deborah Knobelman

Form 4 holding Chief Financial Officer, Head of Corporate Development

Senti Biosciences, Inc.

Security class
Common Stock
Shares / value
131,000
Estimated value
$572,470
Report date
01 Feb 2024
Price
$4.37
Ownership
Direct
Form 4 holding Chief Financial Officer, Head of Corporate Development

Senti Biosciences, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
152,000
Estimated value
Report date
01 Feb 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding President & Interim CEO

Kronos Bio, Inc.

Security class
Employee Stock Option (Right to Buy)
Shares / value
0
Estimated value
Report date
20 Jun 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Deborah Knobelman

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .